Hospira

Hospira to acquire API manufacturing and R&D facilities in India

Thursday, August 30, 2012 11:22 AM

Hospira, a global provider of injectable drugs and infusion technologies, has agreed to acquire an active pharmaceutical ingredient (API) manufacturing facility, together with an associated R&D facility, from Orchid Chemicals & Pharmaceuticals of India for approximately $200 million.

More... »

WIRB Copernicus Group

Hospira to expand operations, create 200 jobs

Wednesday, August 29, 2012 11:20 AM

Hospira, a provider of injectable medicines and infusion technologies, is modernizing and expanding the capabilities of its operations in Nash County of N.C.

More... »


Hospira names Dempsey to board of directors

Thursday, August 18, 2011 01:16 PM

Hospira has named William G. Dempsey to its board of directors. The addition of Dempsey expands Hospira's board to 11 directors, nine of whom are independent.

More... »

FDA approves generic Taxotere

Friday, March 11, 2011 01:47 PM

Hospira has won approval for the first U.S. generic version of Sanofi-aventis’ Taxotere cancer drug, according to a Reuters report.

More... »

Allergen executive takes CEO reins at Hospira

Wednesday, March 9, 2011 01:49 PM

Hospira has named former Allergan President F. Michael Ball its new CEO. The specialty pharma's current chief and founder, Christopher Begley, will become executive chairman.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 25

Verizon Communications enters clinical trial space with technology, network, and cloud and data services

Sponsors look to the power of genomic profiling to screen, enroll patients in trials for targeted therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs